Aphex BioCleanse Systems (Aphex BioCleanse Systems) Cash-to-Debt : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Aphex BioCleanse Systems Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Aphex BioCleanse Systems's cash to debt ratio for the quarter that ended in . 20 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Aphex BioCleanse Systems couldn't pay off its debt using the cash in hand for the quarter that ended in . 20.

The historical rank and industry rank for Aphex BioCleanse Systems's Cash-to-Debt or its related term are showing as below:

SNST's Cash-to-Debt is not ranked ^*
in the Consumer Packaged Goods industry.
Industry Median: 0.52
* Ranked among companies with meaningful Cash-to-Debt only.

Aphex BioCleanse Systems Cash-to-Debt Historical Data

The historical data trend for Aphex BioCleanse Systems's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Aphex BioCleanse Systems Cash-to-Debt Chart

Aphex BioCleanse Systems Annual Data

Trend

Cash-to-Debt

Aphex BioCleanse Systems Quarterly Data

Cash-to-Debt

Competitive Comparison of Aphex BioCleanse Systems's Cash-to-Debt

For the Household & Personal Products subindustry, Aphex BioCleanse Systems's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aphex BioCleanse Systems's Cash-to-Debt Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aphex BioCleanse Systems's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Aphex BioCleanse Systems's Cash-to-Debt falls into.

Aphex BioCleanse Systems Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Aphex BioCleanse Systems's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Aphex BioCleanse Systems's Cash to Debt Ratio for the quarter that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Aphex BioCleanse Systems (OTCPK:SNST) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Aphex BioCleanse Systems Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Aphex BioCleanse Systems's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Aphex BioCleanse Systems (Aphex BioCleanse Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aphex BioCleanse Systems Inc (OTCPK:SNST) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259

Website

https://www.aphexus.com

Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.